Results 311 to 320 of about 245,298 (381)
Response to Commentary on "Sedentary Leisure Behaviour, Physical Activity, and Gastroesophageal Reflux Disease: Evidence From a Mendelian Randomization Analysis". [PDF]
Lu S, Li X, Song Y.
europepmc +1 more source
Accuracy of the diagnosis of gastroesophageal reflux disease by a trial of potassium-competitive acid blocker treatment. [PDF]
Dong P+12 more
europepmc +1 more source
ABSTRACT Objectives A ‘gray color sign’ (GCS) is a new endoscopic feature of fundic gland polyp associated with proton pump inhibitor (PPI‐FGP). Here, we compare the ability of texture and color enhancement imaging (TXI) to white light imaging (WLI) with regard to the detection of GCS. Methods In this prospective study, 19 consecutive patients with PPI‐
Ryota Uchida+17 more
wiley +1 more source
Effectiveness of an educational program about lifestyle habits on patients' knowledge with gastroesophageal reflux disease. [PDF]
Mohammed Ali BR, Atiyah HH.
europepmc +1 more source
ABSTRACT Introduction Anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation (ARMA) are novel endoscopic treatments for proton pump inhibitor or potassium‐competitive acid blocker‐refractory gastroesophageal reflux disease. These procedures induce scarring of the artificial ulcer at the gastric cardia, which tightens the enlarged cardiac ...
Ippei Tanaka+8 more
wiley +1 more source
Medical treatment of gastroesophageal reflux in the neonatal intensive care unit: current practice. [PDF]
Lockyear C+13 more
europepmc +1 more source
ABSTRACT Background and Aims The Endoscopic Pressure Study Integrated System (EPSIS) is a novel endoscopic tool to assess lower esophageal sphincter (LES) function by monitoring intragastric pressure (IGP) through insufflation. While previous studies have confirmed its diagnostic utility for LES dysfunction‐related disorders such as gastroesophageal ...
Miyuki Iwasaki+9 more
wiley +1 more source
Dysregulated Proteostasis-induced Ferroptosis in Gastroesophageal Reflux Disease: Hero or Villain? [PDF]
Wang DH.
europepmc +1 more source
Sodium‐glucose cotransporter‐2 inhibitor confers cardioprotective effects in patients with left ventricular systolic dysfunction and may attenuate the risk of sudden cardiac death through its antiarrhythmic properties. However, the precise mechanisms underpinning the antiarrhythmic potential of SGLT2 inhibitors remain incompletely characterized.
Yusuf Kayhan+8 more
wiley +1 more source
Genetic evidence for amlodipine's protective role in gastroesophageal reflux disease: A focus on CACNB2. [PDF]
Zhang L, Chu Q, Jiang S, Shao B.
europepmc +1 more source